Amarin | Rentekostnader



Interest Expense On Debt Endring Dato
AbbVie USD 610M 19M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amarin USD 0 8K 2024-06
AstraZeneca 429M 28M 2024-12
DBV Technologies 784.71K 632.24K 2022-06
GlaxoSmithKline 173M 17M 2024-12
Halozyme Therapeutics USD 4.54M 16K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12



Amarin Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.